Brenton Flynn

Brenton Flynn


Recent articles

Why Celgene Still Looks Cheap

Motley Fool bureau chief Brenton Flynn discusses his key takeaways from the most notable health care industry earnings reports.

Cubist Earnings: What to Watch

While earnings can sometimes move the needle, this big drug is what investors should really be watching.